Stock Markets June 12, 2026 03:56 AM

Deutsche Bank Opens Coverage on Alzchem With 'Buy' Call, Sets €256 Target

Analyst highlights unique position in calcium carbide and calcium cyanide chains and vertically integrated production model

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn

Deutsche Bank initiated coverage of Alzchem Group AG with a buy recommendation and a price objective of €256, representing roughly 40.8% upside from the stock's most recent close of €181.80. The bank cited the company's distinctive role in the calcium carbide and calcium cyanide value chains and its vertically integrated 'Verbundsystem' as sources of competitive strength, supply security, cost efficiency and production flexibility.

Deutsche Bank Opens Coverage on Alzchem With 'Buy' Call, Sets €256 Target
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Deutsche Bank started coverage of Alzchem Group AG with a buy rating and a price target of €256, implying around 40.8% upside from the last close of €181.80 - impacts equity investors and capital markets assessments.
  • Analyst Manuela Stuerzer cited Alzchem's "unique position" in the calcium carbide and calcium cyanide value chains and emphasized that the company's in-house production of key precursors creates a competitive advantage - relevant to the chemicals and industrials sectors.
  • The bank described Alzchem's operations as a "Verbundsystem," a linked structure of raw materials, intermediates and downstream speciality products that it says supports security of supply, cost efficiency and production flexibility - affecting supply-chain considerations within speciality chemicals.

Deutsche Bank began formal coverage of Alzchem Group AG on Friday, assigning the German speciality chemicals company a "buy" rating and a price target of €256. That target implies an increase of approximately 40.8% from Alzchem's last reported share price of €181.80.

In a note accompanying the initiation, analyst Manuela Stuerzer described Alzchem as occupying a "unique position" within the calcium carbide and calcium cyanide segments of the chemicals value chain. Stuerzer emphasized the company's vertically integrated production approach, writing that in-house manufacture of key precursors makes Alzchem's model hard to duplicate across a range of end markets.

Deutsche Bank characterized Alzchem's operations as being built around a "Verbundsystem" - a linked system that spans raw materials, intermediates and downstream speciality products. According to the bank, this integrated structure underpins the company's security of supply while also supporting cost efficiency and production flexibility.

The bank's initiation presents a multi-faceted view: the rating and target quantify Deutsche Bank's near-term upside case relative to the last close, while the analyst commentary highlights structural advantages in production and value-chain positioning. The note points to vertical integration and an internal supply of precursors as the central features that underpin the firm's competitive edge and create high barriers to entry.

For investors and market participants, the coverage introduces an updated broker view anchored on both valuation upside and operational characteristics. The stated target and the analyst's rationale link equity-market expectations to Alzchem's manufacturing configuration and product chain specialization.


Contextual details from the initiation:

  • Deutsche Bank initiated coverage with a "buy" rating.
  • The bank set a price target of €256, implying about 40.8% upside from the last close of €181.80.
  • Analyst Manuela Stuerzer highlighted Alzchem's position in the calcium carbide and calcium cyanide value chain and its vertically integrated production model.
  • Alzchem's operating model was described using the German term "Verbundsystem," which Deutsche Bank said supports supply security, cost efficiency and production flexibility.

Note on source information - The facts presented here are based on the bank's initiation and the analyst commentary included in that note.

Risks

  • The article does not provide details on potential downside scenarios, company-specific operational risks, or financial assumptions that underpin Deutsche Bank's price target - this gap limits assessment of risks for investors in equities and credit markets.
  • No information is provided on market demand variability or end-market exposure for Alzchem's products; the absence of such detail leaves uncertainty about cyclical or sector-specific demand risks that could affect the speciality chemicals sector.
  • The initiation note, as presented, does not outline competitive responses or barriers eroding over time; the lack of detail means potential competitive or technological risks to Alzchem's position are not quantified in the provided text.

More from Stock Markets

Berenberg Lift Spurs Rally in Rolls-Royce, Safran and MTU as Flight-Hour Trend Favors Younger Engine Fleets Jun 12, 2026 Repsol Shares Slide After Oil Prices Drop on Iran Peace Signal Jun 12, 2026 Fraport Rises on Easing Middle East Tensions and Strong Operational Signals Jun 12, 2026 LPP Shares Drop After Company Scales Back Sinsay Rollout and Lowers 2026 Revenue Target Jun 12, 2026 SpaceX Lists as SPCX: Anatomy of the Largest IPO Ever and What Investors Should Know Jun 12, 2026